Funding · Healthcare & Life Sciences
TRUE ARTIS raises ₹11.4 Cr seed funding led by Zeropearl VC
By Startup Enthusiast ·
- Date
- Company
- TRUE ARTIS
- What it does
- aesthetic surgery platform
- Kind
- Funding
- Amount
- ₹11.4 Cr
- Stage
- seed
- Based in
- Delhi
- Founded
- 2025
What they do
TRUE ARTIS is an aesthetic surgery platform operating in Delhi NCR with two centres and plans to open two more in the next six to eight months
What happened
The seed funding of ₹11.4 Cr is led by Zeropearl VC and includes participation from Eleven, Arjun Vaidya, Dr
Why it matters
Dhruv Joshi, Ambarish Gupta, and Vivek Lohcheb; the company has served over 10,000 clients and completed over 400 surgeries in the past nine months, with…
The details
- TRUE ARTIS raised ₹11.4 crore in a seed funding round led by Zeropearl VC.
- The round also included participation from Eleven, a diversified business group of Medanta co-founder Sunil Sachdeva, and a group of angel investors.
- The funding will be used to open two new centres in Delhi NCR over the next six to eight months.
- The company plans to strengthen its surgical and recovery capabilities, expand its network of plastic and aesthetic surgeons, and develop its technology and patient-care systems.
- TRUE ARTIS currently operates two centres in Delhi and Gurgaon, offering procedures across facial aesthetics, breast surgery, body contouring, and hair restoration.
The bigger picture
- The Indian aesthetic healthcare market is at an inflection point, with consumers placing greater emphasis on outcomes, safety, transparency, and experience.
- TRUE ARTIS aims to build a new category in aesthetic healthcare by integrating clinical care, patient safety, and experience into its operating model.
- The company is seeing demand from international patients and sees medical tourism as a potential area for future growth.
About the business
- TRUE ARTIS operates purpose-built aesthetic surgery centres where procedures are performed on-site.
- Its facilities include operating theatres, surgical and medical equipment, dedicated recovery areas, ICU backup, and private patient suites.
- The company works with a network of full-time and visiting plastic surgeons, allowing patients to consult specialists across different procedures through the same platform.
- TRUE ARTIS has developed an in-house technology system to manage its operations and the patient journey, from initial enquiries and consultations to surgery and post-operative recovery.
- The company has served more than 10,000 clients and completed over 400 surgeries in the past nine months.
What happens next
- TRUE ARTIS plans to open two new centres in Delhi NCR over the next six to eight months.
- The company will invest in strengthening its surgical and recovery capabilities, expanding its network of plastic and aesthetic surgeons, and developing its technology and patient-care systems.
- TRUE ARTIS aims to consolidate its presence in Delhi NCR before expanding into other markets.
The deal
- Type
- funding
Investors
- Zeropearl VC (lead) — A venture capital firm focused on early-stage investments in healthcare and technology.
- Eleven (investor) — A diversified business group founded by Medanta co-founder Sunil Sachdeva.
- Arjun Vaidya (investor) — Co-founder and investment partner at V3 Ventures.
- Dr. Dhruv Joshi (investor) — Co-founder of Cloud Physician.
- Ambarish Gupta (investor) — Founder and CEO of Basis Vectors Capital.
- Vivek Lohcheb (investor) — CBO at PhonePe.
Founders
- Ankit Joshi, co-founder
- Sandeep Upadhyay, co-founder
Other articles talking about it
Same day
- Peak XV sells 1.46% of Groww16 September 2026 · Stake sale · ₹1,756 crore
- Zerodha pushes for UPI fee cap amid new rules16 September 2026 · Policy
- Super.money appoints Rohan Khara as chief product officer16 September 2026 · People
- Factrika raises seed funding for industrial workforce platform16 September 2026 · People · $928K
- Ugro capital raises rs 380 crore from fmo for smes16 September 2026 · Funding · ₹380 crore
- Peak XV and Sequoia sell Groww shares worth ₹1,999 crore16 September 2026 · Stake sale · ₹1,918 crore